Florida Boards

  • Medicine

  • Nursing

  • Dentistry

  • Pharmacy

  • Optometry

  • Massage Therapy

  • Psychology

  • Chiropractic Medicine

  • Occupational Therapy

  • Osteopathic Medicine

  • Physical Therapy

  • Acupuncture

  • Athletic Training

  • Clinical Laboratory Personnel

  • Hearing Aid Specialist

  • Mental Health Professions

  • Nursing Home Administrators

  • Opticianry

  • Orthotists & Prosthetists

  • Podiatric Medicine

  • Respiratory Care

  • Speech-Language Pathology & Audiology


Dietetics and Nutrition Practice | Electrolysis | Licensed Midwifery | Physician Assistants


Certified Master Social Workers | Pain Management Clinics | Dental Laboratories | Paramedics | Emergency Medical Technicians | Radiologic Technicians | Medical Physicists | School Psychologists | Office Surgery Registration

Practice of Pharmacy
Effective Date: July 1, 2020
HB 389 (Full Text)

The bill authorizes a pharmacist to enter into a collaborative pharmacy practice agreement (CPPA) with a physician to manage chronic health conditions if the pharmacist meets certain qualifications. A CPPA must meet certain terms and specify the health conditions, treatments, and tests governed by the CPPA. The bill prohibits a collaborating pharmacist from initiating or prescribing a controlled substance or modifying or discontinuing any medication that is prescribed by a health care practitioner who does not have a CPPA with the pharmacist.

The bill authorizes a pharmacist, who meets certain qualifications, to test or screen for and treat minor, nonchronic health conditions within the framework of a written protocol with a supervising physician. The conditions are limited to influenza, streptococcus, lice, skin conditions, and minor, uncomplicated infections. The protocol must specify the patients that may be seen, instructions for obtaining a patient’s medical history, instructions for treatment, and a process and schedule for the pharmacist to provide patient information to the supervising physician and the supervising physician to review the pharmacist’s actions under the protocol.

The bill requires the Board of Pharmacy to adopt, by rule, a formulary of medicinal drugs that an authorized pharmacist may prescribe to treat minor, non-chronic health conditions. A pharmacist may not prescribe any controlled substance; however, the Board-developed formulary may include any non-controlled substance, including those that typically need a prescription to dispense, such as antibiotics, and over-the-counter medications. The bill authorizes a pharmacist to use certain laboratory or clinical tests, as well as any established screening procedures for which no test is available.

A pharmacy in which a pharmacist provides services for minor, non-chronic health conditions must prominently display a sign advising a patient receiving such services to seek follow-up care from a physician. The Board of Pharmacy must adopt guidelines for advising a patient to seek follow-up care from a physician.

Consultant Pharmacists
Effective Date: July 1, 2020
HB 599 (Full Text)

The bill expands consultant pharmacist scope of practice by authorizing a consultant pharmacist to enter into a written collaborative practice agreement to provide medication management services with a health care facility medical director or Florida-licensed allopathic physician, osteopathic physician, podiatric physician, or dentist to:

  • Order and evaluate laboratory and clinical testing;
  • Conduct patient assessments;
  • Administer medications; and
  • Modify or discontinue medicinal drugs pursuant to a patient-specific order or treatment protocol.

A consultant pharmacist may only provide services to the patients of the health care practitioner with whom the consultant pharmacist has a written collaborative practice agreement. The bill requires both the consultant pharmacist and health care practitioner to maintain a copy of the collaborative agreement and make it available upon request or during an inspection. The bill also requires the consultant pharmacist to maintain all drug, patient care, and quality assurance records.

The bill authorizes a consultant pharmacist to provide services to patients in an ambulatory surgical center, hospital, alcohol or chemical dependency treatment center, inpatient hospice, or ambulatory care center, in addition to those authorized in current law (nursing home and home health agency patients). The bill clarifies that a consultant pharmacist is not authorized to diagnose any disease or condition, and authorizes the Board of Pharmacy to establish additional education requirements for licensure as a consultant pharmacist.

The bill also authorizes a pharmacist to make recommendations regarding the patient’s health care status with the patient’s prescribing health care practitioner or others specifically authorized by the patient.


Direct Care Workers and Autonomous APRNs
Effective Date: Upon Becoming a Law (March 11,2020) and July 1, 2020
HB 607 (Full Text)

The bill authorizes Advanced Practice Registered Nurses (APRN) who meet certain criteria to practice primary care or midwifery without physician supervision or a protocol. The bill also authorizes an advisory council comprised of physicians, APRNs, and the state Surgeon General to make recommendations to the Board of Nursing on the standards of practice for such APRNs. The bill subjects such APRNs to disciplinary action if they commit specified prohibited acts related to unethical and substandard business practices. An APRN engaging in autonomous practice must report adverse incidents to the Department of Health (DOH), which must review each report to determine whether the APRN is subject to disciplinary action.

The bill prohibits an insurer from requiring an insured to access care from an APRN engaging in autonomous practice rather than a physician.

The bill authorizes DOH to award up to $15,000 per year under the Medical Education Reimbursement and Loan Repayment Program to APRNs engaging in autonomous practice and practicing primary care in a public health program or that serves Medicaid recipients and other low-income patients in a primary care shortage area.

The bill authorizes registered nurses to delegate certain tasks to a certified nursing assistant (CNA) or home health aide (HHA), including medication administration. The bill authorizes CNAs and HHAs to assist with preventive skin care, applying bandages, and nebulizer treatments. The bill authorizes the Agency for Health Care Administration to adopt rules training paid feeding assistants in nursing homes and prohibits facilities from counting paid feeding assistants toward minimum staffing standards.

The bill requires all licensed nursing homes, home health agencies, hospices, and homemaker and companion services providers to complete a workforce survey at each biennial licensure renewal.

The bill creates the Excellence in Home Health and Nurse Registry Excellence programs to award designations to home health agencies and nurse registries that meet certain criteria. The home health agency or nurse registry may use the respective designation in marketing materials until such time it no longer holds, or qualifies for, the designation

Senate Bill

Summaries of the enrolled bills from the 2020 legislative session that affect Florida's health care professions. Click on hyperlinks to view a brief summary, effective date and a link to the final enrolled text.



Content provided by the Florida Department of Health presented herein is for informational purposes only. The Department has not screened each individual or organization that appears on this site or that is electronically linked to this site. The appearance of an individual or organization on this site is not intended as or in any manner serves as an endorsement of that individual or organization or any products or services identified on the individual’s or organization’s site. The Department disclaims any and all warranties with regard to the Website and Website information, including without limitation (A) Any implied warranties of merchantability, fitness for a particular purpose, infringement or title, (B) Any warranty of quality, functionality, operability, use or performance of the Website or Website information, (C) Any warranty of the accuracy completeness or validity of data or information communicated through the Website or included in the Website information, (D) Any warranty of the continuous availability of the Website or Website information, or that the Website or Website information will be uninterrupted or error-free, (E) Any warranty that the Website information or other files or data available for access or downloading will be free of infection, viruses, or other code manifesting harmful, contaminating, or destructive properties, or (F) Any warranties arising from course of dealing, trade usage, trade practice or otherwise. In addition, the Department does not represent or warrant that any defects in the Website or errors in the Website information will be corrected. In addition, the department does not warrant either expressly or by implication any individual, organization, product or service appearing on this site or that is electronically linked to this site. The department strongly urges all users of this site to conduct their own investigation of any individual, organization, product or service appearing on this site or that is electronically linked to this site.

Various clipart and image collections appearing on this site are used under license by the department or its web managers for this site. These images are for viewing purposes only. Any reproduction may be prohibited under federal/state copyright or trade secret laws.